Stryker Corporation (SYK)

NYSE: SYK · USD

$304

+2.47 (+0.8%)· Recorded snapshot

Awaryjny angielskiPL

Pokazujemy źródło angielskie podczas tłumaczenia

Ten raport nie został jeszcze przetłumaczony. Odśwież za kilka minut, gdy kolejka tłumaczeń go przetworzy.

StockMarketAgent Research · Analyzed 2026-10-22

Our latest published analysis: SYK rated Hold

Stryker Corporation's published Hold conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$313 / share

Potential value

$413 / share

Upside to FV

+5.2%

from $304

Moat

8.5/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$114.2B
Revenue (ttm)	25.8B
Net income (ttm)	3.7B
EPS (ttm)	$9.65
Shares out	383.6M
P/E (trailing)	31.5x
P/E (forward)	16.5x
Dividend	$3.52 (1.16%)
Volume	1,512,185
Beta	0.78

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 25.8B
Net income (ttm): 3.7B
EPS (ttm): $9.65
P/E (trailing): 31.5x
P/E (forward): 16.5x
Market cap: $114.2B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$17.11B	$18.45B	$20.50B	$22.60B	$25.12B	+10.1%
Gross profit	$10.97B	$11.58B	$13.06B	$14.44B	$16.07B	+10.0%
Operating income	$2.58B	$2.84B	$3.89B	$3.69B	$4.89B	+17.3%
Net income	$1.99B	$2.36B	$3.17B	$2.99B	$3.25B	+13.0%
EPS (diluted)	$5.21	$6.17	$8.25	$7.76	$8.40	+12.7%
EBITDA	$3.61B	$4.02B	$5.06B	$6.01B	$6.31B	+15.0%
R&D	$1.24B	$1.45B	$1.39B	$1.47B	$1.62B	+7.1%
SG&A	$6.43B	$6.39B	$7.11B	$7.69B	$8.65B	+7.7%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	5T	39.4x	10.8x	101.6%	+6.1%	+28.5%	Sprzedaj
ABNB	Airbnb, Inc.	97.8B	37.5x	7.4x	16.8%	+24.4%	+28.5%	Sprzedaj
ADBE	Adobe Inc.	97.1B	13.9x	3.7x	57.2%	+11.5%	-30.7%	Zdecydowanie kupuj
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	Sprzedaj
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	Redukuj
ALGN	Align Technology Inc.	10.9B	26.6x	2.6x	17.2%	+3.6%	+11.6%	Redukuj

Base and Bull scenarios

Bull20%

Price target

$413.44

+38.9% from spot

Accelerated hospital capital equipment spending, record Mako robotic placements in hospital and ASC settings, and rapid clearance of Peripheral Vascular backorders drive double-digit earnings compounding and accelerated operating margin expansion ahead of house expectations.

EPS annual compound growth of 12.5% through explicit forecast horizon.
Adjusted operating margin expands beyond 21.2% ahead of schedule.
Rapid ASC robotic placement acceleration and sustained procedure volume expansion.

Base55%

Price target

$313.18

+5.2% from spot

Stryker executes within its guided organic sales growth corridors, transitioning to steady high-single-digit revenue expansion through FY2030 supported by resilient reconstructive procedure volumes and steady operating margin progression.

FY2026 revenue of $27.17B and adjusted EPS of $14.95.
FY2027 revenue of $29.49B and adjusted EPS of $16.66.
Operating margin expands from 19.5% in FY2026 to 21.2% in FY2030.
Terminal exit P/E multiple of 18.0x and perpetual growth rate of 3.0%.

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($313.18). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	2.5%	2.8%	3.0%	3.3%	3.5%
7.6%	$346	$357	$368	$381	$395
8.1%	$321	$329	$338	$348	$359
8.6%	$299	$306	$313	$321	$330
9.1%	$280	$286	$292	$299	$306
9.6%	$264	$269	$274	$279	$285

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E16.5

P25 n/aP50 n/aP75 n/a

Trailing P/E31.5

P25 n/aP50 n/aP75 n/a

ROE16.5

P25 n/aP50 n/aP75 n/a

ROIC12.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SYK indicators

Market & fundamental data

Available fields

292

Groups with data

Currency

USD

Showing 292 of 292 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000310764
Company name	Stryker Corporation
Country	United States
Country code	US
CUSIP number	863667101
Earnings date	2026-10-29
Earnings time	amc
Employees	56,000
Employees change	3,000
Employees growth	5.66%
Enterprise value	$128.5B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1941
In index	SP500
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US8636671013
Last 10-K release date	2026-02-11
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split date	2004-05-17
Last stock split type	Forward
Market cap	$116.6B
Market cap category	Large-Cap
Next earnings date	2026-10-29
Options	Yes
Price	$303.88
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	SYK
U.S. state	Michigan
Website	https://www.stryker.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	21.78x
Average P/E ratio (10Y)	40.49x
Average P/E ratio (3Y)	41.62x
Average P/E ratio (5Y)	42.15x
Earnings yield	3.18%
EV/Earnings	34.36x
EV/EBIT	20.82x
EV/EBITDA	17.37x
EV/FCF	27.25x
EV/Sales	4.96x
FCF / EV yield	3.67%
FCF yield	4.05%
Forward EV/Sales	4.52x
Forward P/E	19.12x
Forward P/S	4.1x
Graham number	116.52413
Graham upside	-61.52%
Industry forward P/E	19.81x
Industry P/E	39.28x
Lynch fair value	$119.19
Lynch upside	-60.64%
P/(FCF - SBC) ratio	26.1x
P/(OCF - SBC) ratio	22.03x
P/B ratio	4.82x
P/E ratio	31.49x
P/FCF ratio	24.71x
P/OCF ratio	21.03x
P/S ratio	4.5x
PEG ratio	1.78x
Price/EBITDA ratio	15.75x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	23.82%
EBITDA margin	28.55%
Effective tax rate	27.56%
FCF margin	18.2%
Gross margin	65.59%
Operating margin	23.82%
Pretax margin	19.92%
Profit margin	14.43%
Profit per employee	$66,589
Profitable quarters	24
Profitable years	35
Revenue per employee	$461,375
ROA	8.16%
ROA (5Y)	6.99%
ROCE	14.92%
ROE	16.51%
ROE (5Y)	15.51%
ROIC	12.52%
ROIC (5Y)	12.85%
SBC / revenue	0.97%
Tax / revenue	5.49%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	27.79%
EPS growth (Q)	44.11%
EPS growth (QoQ)	70.98%
EPS growth 10Y	8.57%
EPS growth 3Y	10.87%
EPS growth 5Y	12.08%
EPS growth quarters	5
EPS growth years	1
FCF growth	16.85%
FCF growth (Q)	14.12%
FCF growth (QoQ)	155.18%
FCF growth 3Y	24.83%
FCF growth 5Y	9.6%
Gross profit growth	9.54%
Gross profit growth (Q)	15.26%
Gross profit growth 3Y	11.36%
Gross profit growth 5Y	9.73%
Net income growth	27.79%
Net income growth (Q)	44.34%
Net income growth (QoQ)	71.28%
Net income growth 3Y	11.24%
Net income growth 5Y	12.35%
Net income growth quarters	5
Net income growth years	1
OCF growth	15.93%
OCF growth (Q)	13.5%
OCF growth (QoQ)	117.04%
OCF growth 10Y	19.67%
OCF growth 3Y	22.24%
OCF growth 5Y	10.22%
Operating income growth	16.4%
Operating income growth (Q)	34.64%
Operating income growth 3Y	17.73%
Operating income growth 5Y	10.8%
Revenue growth	8.48%
Revenue growth (Q)	9.42%
Revenue growth (QoQ)	9.45%
Revenue growth 10Y	9.45%
Revenue growth 3Y	9.92%
Revenue growth 5Y	9.72%
Revenue growth quarters	24
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-823M
Depreciation and amortization	$1.2B
EBIT	$6.2B
EBITDA	$7.4B
EPS	$9.65
FCF per share	$12.26
Financing cash flow	$-3B
Free cash flow	$4.7B
Free cash flow minus SBC	$4.5B
Gross profit	$16.9B
Income taxes	$1.4B
Investing cash flow	$-1.5B
Net borrowing	$-1.5B
Net cash flow	$1B
Net income	$3.7B
Operating cash flow minus SBC	$5.3B
Operating income	$6.2B
Revenue	$25.8B
Stock-based compensation	$251M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.21
Book value per share	$62.54
Debt / EBITDA	2.04
Debt / equity	0.64
Debt / FCF	3.28
Goodwill	$19.6B
Interest coverage	10.26
Long-term assets	$33.5B
Long-term liabilities	$17.3B
Net cash (debt)	$-12B
Net cash / market cap	-10.3%
Net debt / EBITDA	1.62
Net debt / equity	0.5
Net debt / FCF	2.55
Piotroski F-Score	7
Property, plant and equipment	$4.5B
Shareholders' equity	$24B
Tangible book value	$-1.3B
Tangible book value per share	$-3.49
Total assets	$47.9B
Total cash	$3.5B
Total debt	$15.4B
Total liabilities	$23.9B
WACC	7.87%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.55
Current assets	$14.4B
Current liabilities	$6.7B
Current ratio	2.16
Inventory turnover	1.64
Net working capital	$5.2B
Quick ratio	1.08
Working capital	$7.7B
Working capital turnover	3.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.05%
Dividend growth	4.76%
Dividend growth (10Y)	8.76%
Dividend growth (3Y)	5.47%
Dividend growth (5Y)	6.91%
Dividend growth years	16
Dividend payment date	2026-10-30
Dividend payment years	36
Dividend payout frequency	Quarterly
Dividend per share	$3.52
Dividend yield	1.16%
Ex-dividend date	2026-09-30
FCF payout ratio	28.71%
Last dividend	$0.88
Payout ratio	36.48%
Shareholder yield	1.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	177.12%
10Y return CAGR	11.96%
10Y total return	209.48%
150-day SMA	$312.11
15Y price change	516.13%
15Y return CAGR	14.3%
15Y total return	642.94%
1D price change	0.82%
1M price change	11.64%
1M total return	11.99%
1W price change	-0.11%
1W total return	-0.11%
1Y price change	-20.76%
1Y return CAGR	-19.89%
1Y total return	-19.88%
20-day SMA	$290.10
200-day SMA	$324.38
20Y price change	477.51%
20Y return CAGR	10.44%
20Y total return	628.52%
3M price change	-9.7%
3M total return	-9.42%
3Y price change	16.09%
3Y return CAGR	6.14%
3Y total return	19.58%
50-day SMA	$293.99
50-day SMA vs 200-day SMA	50under200
52-week high	$389.33
52-week high date	2026-03-02
52-week low	$267.00
52-week low date	2026-09-11
5Y price change	13.24%
5Y return CAGR	3.61%
5Y total return	19.38%
6M price change	-7.58%
6M total return	-7.04%
All-time high	$406.19
All-time high date	2025-01-28
All-time low	$0.26
All-time low date	1984-06-08
Average true range (ATR)	$8.12
Average volume	2.4M
Beta (1Y)	0.3
Beta (2Y)	0.55
Beta (5Y)	0.78
Change from 52-week high	-21.95%
Change from 52-week low	13.81%
Change from all-time high	-25.14%
Change from all-time low	116,666.51%
Change from open	1.63%
Day's gap	-0.8%
Dollar volume	$459.5M
High price	$305.29
Low price	$298.81
Monthly RSI	43.46
Open price	$299.00
Position in 52-week range	78.24%
Premarket change	-1.45%
Premarket close	$301.42
Premarket price	$297.06
Premarket volume	1.7K
Previous close	$301.42
Price vs 150-day SMA	-2.58%
Price vs 20-day SMA	4.81%
Price vs 200-day SMA	-6.26%
Price vs 50-day SMA	3.43%
Relative volume	0.63
RSI	59.93
Sharpe ratio	-0.71
Sharpe ratio (3Y)	0.19
Sharpe ratio (5Y)	0.1
Sortino ratio	-0.79
Sortino ratio (3Y)	0.51
Sortino ratio (5Y)	0.36
Volume	1.5M
Weekly RSI	46.99
YTD price change	-13.49%
YTD total return	-12.75%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	348.1M
Float percentage	90.76%
Shares change (QoQ)	-0.13%
Shares change (YoY)	0.05%
Shares held by insiders	9.14%
Shares held by institutions	81.99%
Shares outstanding	383.6M
Short % of float	1.65%
Short % of shares	1.5%
Short ratio	1.9 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	110

Deeper analysis on SYK

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this SYK report

What is the latest published SYK stock rating?

Stryker Corporation is shown with Hold in the latest published report, analyzed 2026-10-22. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SYK analysis?

The full latest published report, analyzed 2026-10-22, lives at /stocks/SYK/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for SYK?

The latest published report analyzed 2026-10-22 gives SYK a fair value of USD 313 and a potential value of USD 413. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the SYK page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-10-22). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

HoldSYK · Fair value $313+5.2%

Read full analysis →

Stryker Corporation (SYK)

Our latest published analysis: SYK rated Hold

Price

Financial snapshot

Fair-value bridge

Latest news · SYK

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All SYK indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on SYK

Frequently asked questions

Historia rekomendacji

Category	Score	Reading
Valuation	6.0
Management	9.5
Balance Sheet	7.5
Profitability	6.5
Revenue Growth	6.0
Risk Assessment	8.0
Competitive Moat	8.5
Earnings Quality	9.0
Capital Efficiency	6.5